Allianz Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Allianz Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-17,483	Closed	-$323K	–	2786
2017 Q3	$323K	Sell	17,483 -112,323	-87%	-$2.09M	﹤0.01%	2513
2017 Q2	$2.39M	Sell	129,806 -5,525	-4%	-$109K	﹤0.01%	1915
2017 Q1	$3.05M	Sell	135,331 -51,198	-27%	-$1.23M	﹤0.01%	1837
2016 Q4	$6.49M	Buy	+186,529	New	+$5.57M	0.01%	1546
2015 Q4	–	Sell	-128,460	Closed	-$5.1M	–	2547
2015 Q3	$5.1M	Sell	128,460 -221,374	-63%	-$13.7M	0.01%	1273
2015 Q2	$24.2M	Sell	349,834 -115,313	-25%	-$7.25M	0.03%	706
2015 Q1	$25.4M	Buy	465,147 +60,199	+15%	+$2.87M	0.03%	605
2014 Q4	$17.3M	Buy	+404,948	New	+$14.6M	0.02%	771
2014 Q3	–	Sell	-8,800	Closed	-$182K	–	2396
2014 Q2	$182K	Buy	8,800 +5,000	+132%	+$92.4K	﹤0.01%	1808
2014 Q1	$74K	Hold	3,800	–	–	﹤0.01%	1879
2013 Q4	$92K	Hold	3,800	–	–	﹤0.01%	1800
2013 Q3	$82K	Hold	3,800	–	–	﹤0.01%	1728
2013 Q2	$85K	Buy	+3,800	New	+$83.7K	﹤0.01%	1689

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management's AMAG Position: Q4 2017 in Review

Allianz Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2017, closing a stake of 17,483 shares — an estimated $323K sold.

Allianz Asset Management first reported a position in AMAG in Q2 2013 and held it in 13 quarters. The position peaked at $25.4M in Q1 2015. 170 funds tracked by Wall St. Rank hold AMAG as of Q4 2017.

Allianz Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Allianz Asset Management sold 17,483 AMAG Pharmaceuticals shares in Q4 2017, an estimated $323K.
Allianz Asset Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 13 quarters.
Allianz Asset Management's AMAG Pharmaceuticals position peaked at $25.4M in Q1 2015.
170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2017.

Based on Allianz Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.